Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hep C… and Me?

A hookup mentioned hepatitis C. It made me question my life. Should I be getting tested for hep C? Did I need to be asking tricks about their status? Was my blissful ignorance about hep C a problem?

Published
29 May 2015
From
BETA blog
Panel: Compulsory licensing could address high-priced medicines in Europe

The high prices of medicine, which affects access to affordable medicine, was a theme of the annual World Health Assembly over the past week. In one side event, a panel discussed compulsory licensing as a vehicle to be used in combatting the high prices of medicine, not only in developing countries, but in Europe.

Published
29 May 2015
From
Intellectual Property Watch
Consumers Sue Anthem for Denying Coverage for a Hepatitis C Drug

The controversy over the new crop of hepatitis C treatments has taken yet another turn as consumers are starting to file lawsuits against insurers that deny them access to the medicines. Over the past two weeks, two different women alleged that Anthem Blue Cross refused to pay for the Harvoni treatment sold by Gilead Sciences because it was not deemed “medically necessary.”

Published
28 May 2015
From
Wall Street Journal
NHS England accused of interference over hepatitis C drug

Officials at NHS England have been accused of interfering in a process to decide whether a drug which can cure Hepatitis C should be made available to patients on the health service.

Published
26 May 2015
From
Channel 4 News
Hepatitis C treatment for people in prison may be highly cost-effective in England

Reducing the duration of direct-acting antiviral treatment for hepatitis C will make treatment for people in prison in England highly cost-effective, and could provide an important opportunity

Published
21 May 2015
By
Keith Alcorn
Hepatitis B and C - An Action Plan for Saving Lives in Europe

Last year, leading experts, institutions, patient organisations and pharmaceutical industry representatives met and agreed that the major recommendations produced between 2011 and 2014 should be compiled into one comprehensive document, to make it easier for policy makers, decision makers, civil society organisations and healthcare institutions to tackle viral hepatitis effectively.

Published
20 May 2015
From
European Liver Patients Association
HIV Outbreak: Why Austin? Why Indiana?

I think the reason we see it here is because we found it. Many areas of the country are experiencing, along with drug abuse, especially in smaller, rural towns, high unemployment, lower incomes and a lack of education. Sadly, there are places in this country where the future looks bleak

Published
20 May 2015
From
WHAS 11.com
Pricing remains main barrier to HCV eradication

Eradication is technically feasible, Dr. Edlin said during a Monday morning AASLD Clinical Symposium, but not likely until current pricing policies change.

Published
20 May 2015
From
Digestive Disease Week News
Achillion partners with J&J to develop hepatitis C drugs

Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.

Published
20 May 2015
From
Reuters
Is Gilead Sciences Its Own Worst Enemy?

Gilead's science is so good that it's actually destroying the company's business. Pharma companies, like most other businesses, make the bulk of their money through repeat business. Gilead, however, is doing something really no other drugmaker is doing -- namely curing patients of devastating infectious diseases.

Published
20 May 2015
From
Motley Fool
← First12345...168Next →

Filter by country